FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, pharmacology and concerns an oral granulated dosage form in sachets containing phospholipids in the form of particles of small (20-30 nm) diameter, glycyrrhizic acid and its salt (including sodium glycerrhizinate), as well as carbohydrate (including maltose) and excipients (granulation, anti-clotting and powder), as well as to a method for preparing it by mixing fat and water phases of herbal phospholipids and acceptable carbohydrate to prepare an emulsion, cooling to 50°C and passing through a microfluidiser for 4-5 cycles under pressure 2000 atm.
EFFECT: preparation shows high activity.
6 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
NANOFORM OF PHOSPHOLIPID PREPARATION FOR ORAL APPLICATION AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2373924C1 |
COMPOSITION OF DIHYDROQUERCETINE ENCLOSED IN PHOSPHOLIPID NANOPARTICLES | 2013 |
|
RU2536208C1 |
PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL APPLICATION FOR INCREASE OF DRUG ACTIVITY AND DECREASE OF SIDE EFFECTS | 2010 |
|
RU2469706C2 |
LIPOSOME SUSPENSION STABILISER AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2529179C1 |
METHOD FOR PREPARING INJECTION MEDICINAL FORMULATION OF PHOSPHOLIPID PREPARATION "FOSFOGLIV" FOR TREATMENT AND PROPHYLAXIS OF ACUTE AND CHRONIC HEPATIC DISEASES | 2005 |
|
RU2304430C2 |
LIPOSOMAL COMPOSITION, METHOD FOR PREPARATION AND USE THEREOF | 2023 |
|
RU2821794C1 |
COMPOSITION EXHIBITING PROPERTY FOR BIOLOGICAL MEMBRANE REPAIRING | 1998 |
|
RU2133122C1 |
METHOD FOR PREPARING MAGNET-SENSITIVE LIPID COMPOSITE | 2012 |
|
RU2502505C2 |
PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
PHOSPHOLIPID SUSPENSION CONTAINING DIHYDROQUERCETIN AND METHOD FOR PRODUCING | 2007 |
|
RU2369383C2 |
Authors
Dates
2012-10-10—Published
2010-11-03—Filed